These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7597874)

  • 1. Treatment of Clostridium difficile colitis. Summary of a round table held in Brussels on March, 3rd, 1994.
    Delmée M; Melin P; Peetermans W; Verbist L; Verschraegen G
    Acta Clin Belg; 1995; 50(2):114-6. PubMed ID: 7597874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis.
    Teasley DG; Gerding DN; Olson MM; Peterson LR; Gebhard RL; Schwartz MJ; Lee JT
    Lancet; 1983 Nov; 2(8358):1043-6. PubMed ID: 6138597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of Clostridium difficile in pseudomembranous and antibiotic-associated colitis.
    Panichi G
    Chemioterapia; 1987 Jun; 6(2 Suppl):493-4. PubMed ID: 2978388
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral metronidazole in Clostridium difficile colitis.
    Mogg GA; Burdon DW; Keighley M
    Br Med J; 1979 Aug; 2(6185):335. PubMed ID: 476461
    [No Abstract]   [Full Text] [Related]  

  • 5. Clostridium difficile colitis: review of the therapeutic approach.
    Joseph J; Singhal S; Patel GM; Anand S
    Am J Ther; 2014; 21(5):385-94. PubMed ID: 22990077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile colitis: recent therapeutical and immunological considerations.
    Delmée M; Warny M
    Acta Gastroenterol Belg; 1995; 58(3-4):313-7. PubMed ID: 7491844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent refractory Clostridium difficile colitis treated successfully with rifaximin and tigecycline: a case report and review of the literature.
    El-Herte RI; Baban TA; Kanj SS
    Scand J Infect Dis; 2012 Mar; 44(3):228-30. PubMed ID: 22077098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
    Tart SB
    J Pharm Pract; 2013 Oct; 26(5):488-90. PubMed ID: 23940121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile and Entamoeba histolytica infections in patients with colitis in the Philippines.
    Warren CA; Labio E; Destura R; Sevilleja JE; Jamias JD; Daez ML
    Trans R Soc Trop Med Hyg; 2012 Jul; 106(7):424-8. PubMed ID: 22657531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Best strategies in recurrent or persistent Clostridium difficile infection.
    Cocanour CS
    Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of outcomes with vancomycin or metronidazole for mild-to-moderate Clostridium difficile associated diarrhea among solid organ transplant recipients: A retrospective cohort study.
    Nguyen CT; Li J; Anders S; Garcia-Diaz J; Staffeld-Coit C; Hand J
    Transpl Infect Dis; 2018 Jun; 20(3):e12867. PubMed ID: 29512244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diarrhoea caused by Clostridium difficile: response time for treatment with metronidazole and vancomycin.
    Wilcox MH; Howe R
    J Antimicrob Chemother; 1995 Oct; 36(4):673-9. PubMed ID: 8591942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile colitis associated with the use of antineoplastic agents.
    Miller SD; Koornhof HJ
    Eur J Clin Microbiol; 1984 Feb; 3(1):10-3. PubMed ID: 6705768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse of antibiotic associated colitis: endogenous persistence of Clostridium difficile during vancomycin therapy.
    Walters BA; Roberts R; Stafford R; Seneviratne E
    Gut; 1983 Mar; 24(3):206-12. PubMed ID: 6826104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Individualized treatment strategies for Clostridium difficile infections].
    Solbach P; Dersch P; Bachmann O
    Internist (Berl); 2017 Jul; 58(7):675-681. PubMed ID: 28589214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Approach to the treatment of intestinal infectious diseases caused by Clostridium difficile].
    Nyc O
    Klin Mikrobiol Infekc Lek; 2010 Jun; 16(3):93-6. PubMed ID: 20640987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASHP therapeutic position statement on the preferential use of metronidazole for the treatment of Clostridium difficile-associated disease.
    Am J Health Syst Pharm; 1998 Jul; 55(13):1407-11. PubMed ID: 9659970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial.
    Johnson S; Homann SR; Bettin KM; Quick JN; Clabots CR; Peterson LR; Gerding DN
    Ann Intern Med; 1992 Aug; 117(4):297-302. PubMed ID: 1322075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emphysematous cystitis due to recurrent Clostridium difficile infection.
    van Genderen ME; Jonkman JG; van Rijn M; Dees A
    BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25519862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.